These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease. Moore CM; Emberton M; Bown SG Lasers Surg Med; 2011 Sep; 43(7):768-75. PubMed ID: 22057504 [TBL] [Abstract][Full Text] [Related]
9. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer. Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy for focal ablation of the prostate. Arumainayagam N; Moore CM; Ahmed HU; Emberton M World J Urol; 2010 Oct; 28(5):571-6. PubMed ID: 20454966 [TBL] [Abstract][Full Text] [Related]
11. A PSMA-targeted theranostic agent for photodynamic therapy. Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for prostate cancer--a review of current status and future promise. Moore CM; Pendse D; Emberton M Nat Clin Pract Urol; 2009 Jan; 6(1):18-30. PubMed ID: 19132003 [TBL] [Abstract][Full Text] [Related]
13. Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway. Liu T; Wu LY; Choi JK; Berkman CE Int J Oncol; 2010 Apr; 36(4):777-84. PubMed ID: 20198319 [TBL] [Abstract][Full Text] [Related]
14. Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy-A review. Kawczyk-Krupka A; Wawrzyniec K; Musiol SK; Potempa M; Bugaj AM; SieroĊ A Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):567-74. PubMed ID: 26467273 [TBL] [Abstract][Full Text] [Related]
15. Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Du KL; Mick R; Busch TM; Zhu TC; Finlay JC; Yu G; Yodh AG; Malkowicz SB; Smith D; Whittington R; Stripp D; Hahn SM Lasers Surg Med; 2006 Jun; 38(5):427-34. PubMed ID: 16788929 [TBL] [Abstract][Full Text] [Related]
16. Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Yu G; Durduran T; Zhou C; Zhu TC; Finlay JC; Busch TM; Malkowicz SB; Hahn SM; Yodh AG Photochem Photobiol; 2006; 82(5):1279-84. PubMed ID: 16696593 [TBL] [Abstract][Full Text] [Related]
17. Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: A review. Casas A Cancer Lett; 2020 Oct; 490():165-173. PubMed ID: 32534172 [TBL] [Abstract][Full Text] [Related]
18. Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies. Nogueira L; Tracey AT; Alvim R; Reisz P; Scherz A; Coleman JA; Kim K Molecules; 2020 Nov; 25(22):. PubMed ID: 33228126 [TBL] [Abstract][Full Text] [Related]
19. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Zhu TC; Dimofte A; Finlay JC; Stripp D; Busch T; Miles J; Whittington R; Malkowicz SB; Tochner Z; Glatstein E; Hahn SM Photochem Photobiol; 2005; 81(1):96-105. PubMed ID: 15535736 [TBL] [Abstract][Full Text] [Related]
20. Clinical application of photodynamic diagnosis and photodynamic therapy for gynecologic malignant diseases: A review. Matoba Y; Banno K; Kisu I; Aoki D Photodiagnosis Photodyn Ther; 2018 Dec; 24():52-57. PubMed ID: 30172075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]